ATLASZenas BioPharma (ZBIO) earnings date: expected December 30 – January 5
Zenas BioPharma (ZBIO) has not announced its next earnings date yet. Based on its last 2 reports, ATLAS expects it around December 30 – January 5. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ZBIO
| Last price | $27.59 (-2.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.0% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Zenas BioPharma stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around December 30 – January 5 (estimate). One email the day before, with ATLAS’s read on Zenas BioPharma. You can switch it off at any time.
Alert me before ZBIO reportsFree to start. Creating an account takes under a minute.
Notify me when Zenas BioPharma reports
Track ZBIO free Add Zenas BioPharma to a free ATLAS watchlist and see its next report date in one place.
ZBIO earnings at a glance
| Next report | Not announced · expected around December 30 – January 5 (ATLAS estimate) |
|---|---|
| Last report | Aug 13, 2026 · Miss |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | -24.6% |
| Average move around a report | ±4.7% (last 5) |
| Sector | Healthcare · Biotechnology |
The expected window is an ATLAS estimate: it takes the typical gap between Zenas BioPharma’s last 2 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Zenas BioPharma earnings history: last 5 reports
Zenas BioPharma last reported on Aug 13, 2026: EPS of -$1.77 against an estimate of -$0.75 (-136.0% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$0.75 | -$1.77 | -136.0% | Miss | -5.7% |
| Jun 3, 2026 | $0.87 | $0.91 | +4.6% | Beat | +7.3% |
| May 13, 2026 | -$1.54 | -$1.46 | +5.2% | Beat | -1.4% |
| Apr 28, 2026 | $4.82 | $4.97 | +3.1% | Beat | -5.6% |
| Apr 16, 2026 | $1.15 | $1.15 | 0.0% | In line | +3.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ZBIO
See the fair value, the probability range and the earnings history of Zenas BioPharma on its ATLAS page.
Zenas BioPharma (ZBIO) stock analysisPlans from €3.99 a month.
Zenas BioPharma earnings: frequently asked questions
When is Zenas BioPharma (ZBIO) next earnings date?
Zenas BioPharma has not announced its next report. Its last 2 reports came Aug 13, 2026, Jun 3, 2026, so ATLAS estimates the next one around December 30 – January 5. This is an estimate based on that pattern, not a confirmed date.
How often does ZBIO beat earnings estimates?
Of its last 5 reports with a recorded result, Zenas BioPharma beat the EPS estimate 3 times; the average surprise was -24.6%. Past results do not predict the next one.
How much does ZBIO move around earnings?
Over its last 5 reports the stock moved an average of 4.7% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Zenas BioPharma beat earnings estimates last quarter?
Zenas BioPharma last reported on Aug 13, 2026: EPS of -$1.77 against an estimate of -$0.75 (-136.0% surprise), a miss.
How much does ZBIO usually move in a day?
On a normal trading day the ATLAS model puts ZBIO’s one-day range at about ±4.0%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer